Cumberland Pharmaceuticals
CPIX
27 hedge funds and large institutions have $12.9M invested in Cumberland Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
0.58% less ownership
Funds ownership: 27.2% → 26.62% (-0.58%)
6% less capital invested
Capital invested by funds: $13.8M → $12.9M (-$858K)
10% less funds holding
Funds holding: 30 → 27 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$49.3K |
| 2 |
BlackRock
New York
|
+$24.8K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$7.89K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.19K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$740 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$286K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$104K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
-$43K |
| 4 |
Morgan Stanley
New York
|
-$7.96K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$6.35K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| – | -$6K | -1,755 | Closed |
|
|
PAG
27
Private Advisor Group
Morristown,
New Jersey
| – | -$1K | -400 | Closed |
|
28
Wells Fargo
San Francisco,
California
| – | +$7 | +2 | +4% |
|
CPIX Hedge Fund Activity: Q3 2020 in Review
27 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q3 2020, worth a combined $12.9M — down 6.2% from $13.8M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CPIX and 1 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 7 added.
The largest buyer was Parametric Portfolio Associates, opening a new position worth an estimated $49.3K. The largest seller was Stonepine Capital Management, cutting an estimated $286K.
- 27 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q3 2020, down from 30 in Q2 2020.
- Funds reported $12.9M of Cumberland Pharmaceuticals stock for Q3 2020, down 6.2% quarter-over-quarter.
- 1 fund opened new Cumberland Pharmaceuticals positions in Q3 2020 and 4 closed out, a net change of -3 holders.
- The largest Cumberland Pharmaceuticals buyer in Q3 2020 was Parametric Portfolio Associates, an estimated $49.3K added.
- The largest Cumberland Pharmaceuticals seller in Q3 2020 was Stonepine Capital Management, an estimated $286K sold.
Based on aggregated 13F filings for Q3 2020.